- | Pays :
- Netherlands
- | Organes : -
- | Spécialités : -
Extrait
This is a first-in-humans study of SRA-444. This study will provide an initial assessment of the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of SRA-444 (SR formulation) after administration of ascending single oral doses to healthy adult subjects.
Critère d'inclusion
- Alzheimer Disease